Researchers using injectable GHK-Cu should follow sterile preparation protocols to prevent contamination-related adverse events, which are procedural rather than compound-specific risks
Importantly, this is the first biologic to show a truly meaningful level of clinical effect in patients, which could expand the number of patients we can treat with this immune disorder," said Jonathan Silverberg, Dermatologist at The George Washington University School of Medicine and Health Sciences, in the press release
Tregs express cytotoxic T-lymphocyte-associated protein-4, lymphocyte-activating gene-3, and neuropilin-1 to suppress DC functions [96]
EMD Millipore) using a Vanquish Flex UHPLC (Thermo Fisher Scientific, Waltham, MA, USA) with buffer A (acetonitrile) and buffer B (20 mM ammonium carbonate, 0.1% ammonium hydroxide, pH 9)
Stay tuned for updates.